Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lipomax J Sachet is an oral liposomal iron food supplement developed by AGP specifically formulated for children above 3 years of age. It contains elemental iron (as iron pyrophosphate microencapsulated in a liposomal form), vitamin C (ascorbic acid), and vitamin B12 (methylcobalamin). The liposomal vehicle technology protects the iron pyrophosphate within a phospholipid membrane, which acts as a protective shell. This formulation allows for enhanced gastrointestinal absorption and higher bioavailability of the mineral with a lower incidence of side effects, such as gastric irritation, compared to conventional oral iron formulations. Lipomax J Sachet is indicated as a daily supplement to prevent and treat iron deficiency conditions, support immune function, promote growth, and prevent fatigue in children during periods of rapid growth or increased physical and mental activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lipomax J Sachet.